Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TAX PROVISION
Tax Provision RARE - Ultragenyx Pharmaceutical Inc.
-1.82 M
LAST VALUE
-65.77%
2 YEAR CAGR
-35.40%
5 YEAR CAGR
4.87%
10 YEAR CAGR